MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium… Read more
MedCap AB (publ) (MCAP) - Total Liabilities
Latest total liabilities as of December 2025: Skr1.15 Billion SEK
Based on the latest financial reports, MedCap AB (publ) (MCAP) has total liabilities worth Skr1.15 Billion SEK as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MedCap AB (publ) - Total Liabilities Trend (2007–2025)
This chart illustrates how MedCap AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MedCap AB (publ) Competitors by Total Liabilities
The table below lists competitors of MedCap AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Top Resource Conservation Engineering Co Ltd
SHE:300332
|
China | CN¥3.47 Billion |
|
Pell Bio-Med Technology Co., Ltd.
TW:6949
|
Taiwan | NT$385.71 Million |
|
Jiangxi Ganneng Co Ltd
SHE:000899
|
China | CN¥13.23 Billion |
|
MorningStar Partners, L.P.
NYSE:TXO
|
USA | $639.94 Million |
|
Si-Bone Inc
NASDAQ:SIBN
|
USA | $62.15 Million |
|
CGN Nuclear Technology Development Co Ltd
SHE:000881
|
China | CN¥4.75 Billion |
|
Senton Energy Co. Ltd. A
SHE:001331
|
China | CN¥179.80 Million |
|
Kunshan Guoli Electronic Technology Co Ltd
SHG:688103
|
China | CN¥1.40 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down MedCap AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.75 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MedCap AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MedCap AB (publ) (2007–2025)
The table below shows the annual total liabilities of MedCap AB (publ) from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr1.15 Billion | +63.13% |
| 2024-12-31 | Skr703.20 Million | +10.72% |
| 2023-12-31 | Skr635.10 Million | +11.30% |
| 2022-12-31 | Skr570.60 Million | +20.94% |
| 2021-12-31 | Skr471.80 Million | -1.56% |
| 2020-12-31 | Skr479.30 Million | -5.93% |
| 2019-12-31 | Skr509.50 Million | +28.95% |
| 2018-12-31 | Skr395.10 Million | +18.83% |
| 2017-12-31 | Skr332.50 Million | +22.75% |
| 2016-12-31 | Skr270.88 Million | -17.56% |
| 2015-12-31 | Skr328.57 Million | +22.36% |
| 2014-12-31 | Skr268.52 Million | -29.17% |
| 2013-12-31 | Skr379.09 Million | +123.95% |
| 2012-12-31 | Skr169.28 Million | +20.15% |
| 2011-12-31 | Skr140.88 Million | +8.34% |
| 2010-12-31 | Skr130.04 Million | -3.61% |
| 2009-12-31 | Skr134.90 Million | +102.90% |
| 2008-12-31 | Skr66.49 Million | -2.36% |
| 2007-12-31 | Skr68.10 Million | -- |